Regulus Therapeutics Inc (RGLS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4224 CAMPUS POINT COURT SAN DIEGO, CA 92121

Regulus Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, CA.

Data as of 2021-08-02 08:24:01 -0400
Market Cap52.739 Million Shares Outstanding74.924 Million Avg 30-day Volume937.266 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-8.45 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.02144 52-week High/Low2.32 / 0.4222 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -10.3041
Data provided by IEX Cloud
View SEC Filings from RGLS instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 45 32 40.63% 17 (1.0%) 12 (0.7%) 41.67%
13F shares: 27.289 Million 18.413 Million 48.2% 16.506 Million 9.518 Million 73.41%
% Ownership 37.637 27.5229 36.75% 22.7649 14.2275 60.01%
New Positions: 20 11 81.82% 8 5 60.0%
Increased Positions 10 8 25.0% 5 3 66.67%
Closed Positions 7 7 0.0% 3 2 50.0%
Reduced Positions 5 3 66.67% 2
Total Calls 513.212 Thousand 173.65 Thousand 195.54% 66.6 Thousand 0
Total Puts 85.234 Thousand 46.26 Thousand 84.25% 16.5 Thousand
PUT/CALL Ratio 0.17 0.27 -37.04% 0.25 -7.41%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RGLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RGLS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PAPADOPOULOS STELIOS

  • Director
40,000 2021-06-14 3

BALTIMORE DAVID

  • Director
40,000 2021-06-14 1

RASTETTER WILLIAM H

  • Director
40,000 2021-06-14 1

ROSEN HUGH

  • Director
40,000 2021-06-14 1

WITZ PASCALE

  • Director
40,000 2021-06-14 1

COLLIER KATHRYN J

  • Director
40,000 2021-06-14 1

SIMEONIDIS SIMOS

  • Director
40,000 2021-06-14 1

NUNN JASON RALEIGH

  • Director
40,000 2021-06-14 1

HUANG ALICE SHIH-HOU

  • Director
40,000 2021-06-14 3

HAGAN JOSEPH P PRESIDENT AND CEO

  • Officer
  • Director
316,292 2021-05-17 8

AKER CHRISTOPHER RAY SR. VP & GENERAL COUNSEL

  • Officer
41,754 2021-05-17 5

MAKHZOUMI MOHAMAD

  • FORMER 10% OWNER
No longer subject to file 2021-03-09 2

FLORENCE ANTHONY A. JR.

  • FORMER 10% OWNER
No longer subject to file 2021-03-09 2

BASKETT FOREST

  • FORMER 10% OWNER
No longer subject to file 2021-03-09 2

GROWTH EQUITY OPPORTUNITIES V, LLC

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2021-03-09 1

SONSINI PETER W.

  • FORMER 10% OWNER
No longer subject to file 2021-03-09 2

SANDELL SCOTT D

  • FORMER 10% OWNER
No longer subject to file 2021-03-09 2

MAKOWER JOSHUA

  • FORMER 10% OWNER
No longer subject to file 2021-03-09 2

BEHBAHANI ALI

  • FORMER 10% OWNER
No longer subject to file 2021-03-09 2

CHANG CARMEN

  • FORMER 10% OWNER
No longer subject to file 2021-03-09 2

WALKER PAUL EDWARD

  • FORMER 10% OWNER
No longer subject to file 2021-03-09 2

CALSADA CRISPINA CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-04 1

DRYGIN DENIS CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-04 1

HUANG ALICE SHIH-HOU

BALTIMORE DAVID

  • Director
0 2021-01-06 3

SARISSA CAPITAL MASTER FUND II LP

  • 10% Owner
76,356 2020-04-01 0

SARISSA CAPITAL OFFSHORE MASTER FUND LP

  • 10% Owner
0 2020-04-01 0

BARRIS PETER J

  • 10% Owner
2,052,454 2019-12-24 0

MOTT DAVID M

  • 10% Owner
2,052,454 2019-12-24 0

DENNER ALEXANDER J

SARISSA CAPITAL MANAGEMENT LP

SARISSA CAPITAL OFFSHORE MASTER FUND LP

SARISSA CAPITAL CATAPULT FUND LLC

SARISSA CAPITAL HAWKEYE FUND LP

  • 10% Owner
0 2019-12-24 0

CHEVALLARD DANIEL R. CHIEF FINANCIAL OFFICER

  • Officer
77,870 2019-07-01 0

WRIGHT TIMOTHY MICHAEL CHIEF R & D OFFICER

  • Officer
62,893 2019-02-05 0

DEEG MARK ALBERT CHIEF MEDICAL OFFICER

  • Officer
0 2018-05-17 0

FOLETTA MARK G

  • Director
81,910 2017-12-04 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
11,108,515 2017-11-17 0

SAKODA JON

  • 10% Owner
10,989,010 2017-07-24 0

PUTTAGUNTA CHETAN

  • 10% Owner
10,989,010 2017-07-24 0

VISWANATHAN RAVI

  • 10% Owner
10,989,010 2017-07-24 0

GRINT PAUL C PRESIDENT & CEO

  • Officer
  • Director
0 2017-02-15 0

WILLIAMS DOUGLAS E

  • Director
0 2016-06-02 0

ALNYLAM PHARMACEUTICALS, INC.

  • 10% Owner
No longer subject to file 2016-02-23 0

ISIS PHARMACEUTICALS INC

  • 10% Owner
No longer subject to file 2015-07-15 0

CARTER BRUCE L A

  • Director
0 2015-06-10 0

XANTHOPOULOS KLEANTHIS G PRESIDENT AND CEO

  • Officer
  • Director
83,921 2015-04-17 0

GIBSON NEIL W CHIEF SCIENTIFIC OFFICER

  • Officer
0 2015-01-28 0

SZEKERES DAVID LESLIE CHIEF BUSINESS OFFICER & GC

  • Officer
0 2014-12-02 0

ASTRAZENECA PLC

ASTRAZENECA AB

  • 10% Owner
4,250,000 2014-11-12 0

ISIS PHARMACEUTICALS INC

PARSHALL B LYNNE

  • Director
  • 10% Owner
5,516,305 2014-11-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

COLLIER KATHRYN J - Director

2021-06-15 16:40:47 -0400 2021-06-14 A 40,000 a 40,000 direct

SIMEONIDIS SIMOS - Director

2021-06-15 17:17:46 -0400 2021-06-14 A 40,000 a 40,000 direct

NUNN JASON RALEIGH - Director

2021-06-15 16:43:13 -0400 2021-06-14 A 40,000 a 40,000 direct

RASTETTER WILLIAM H - Director

2021-06-15 16:44:53 -0400 2021-06-14 A 40,000 a 40,000 direct

HUANG ALICE SHIH-HOU - Director

2021-06-15 16:42:09 -0400 2021-06-14 A 40,000 a 40,000 direct

WITZ PASCALE - Director

2021-06-15 16:46:59 -0400 2021-06-14 A 40,000 a 40,000 direct

BALTIMORE DAVID - Director

2021-06-15 16:39:48 -0400 2021-06-14 A 40,000 a 40,000 direct

ROSEN HUGH - Director

2021-06-15 16:45:35 -0400 2021-06-14 A 40,000 a 40,000 direct

PAPADOPOULOS STELIOS - Director

2021-06-15 16:43:26 -0400 2021-06-14 A 40,000 a 40,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
REGULUS THERAPEUTICS INC RGLS 2021-08-03 15:15:03 UTC -8.4732 8.5332 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-03 14:45:04 UTC -8.4732 8.5332 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-03 14:15:03 UTC -8.4732 8.5332 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-03 13:45:03 UTC -8.4732 8.5332 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-03 13:15:03 UTC -8.4732 8.5332 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-03 12:45:03 UTC -8.4732 8.5332 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 22:15:03 UTC -8.4732 8.5332 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 21:45:03 UTC -8.4732 8.5332 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 21:15:03 UTC -8.4732 8.5332 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 20:45:03 UTC -8.4788 8.5388 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 20:15:03 UTC -8.4788 8.5388 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 19:45:03 UTC -8.4788 8.5388 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 19:15:03 UTC -8.4788 8.5388 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 18:45:03 UTC -8.4788 8.5388 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 18:15:03 UTC -8.4788 8.5388 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 17:45:03 UTC -8.4788 8.5388 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 17:15:03 UTC -8.4788 8.5388 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 16:45:03 UTC -8.4748 8.5548 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 16:15:03 UTC -8.4748 8.5548 1000000
REGULUS THERAPEUTICS INC RGLS 2021-08-02 15:45:03 UTC -8.4748 8.5548 1000000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Regulus Therapeutics Inc 1.19% 2019-08-28 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.69% 2019-09-16 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.78% 2019-09-11 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.58% 2019-09-19 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 1.4% 2019-08-05 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 1.39% 2019-08-20 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.97% 2019-09-05 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 1.09% 2019-08-30 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.89% 2019-09-09 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 1.29% 2019-08-23 GERMANY

Elevate your investments